FGF7 and graft versus host disease: Several groups postulated that, based on the GI primacy model of acute GVHD 65–66, KGF administration would reduce GI tract damage and consequently result in less cytokine release, decreased gut bacteria translocation and, thus, a lower incidence of GVHD.